Lisa Giles

Lisa Giles is an experienced executive in the biotech and pharmaceutical industries with a proven track record of leadership in strategic program management and alliance management. Currently serving as Head of Alliance Management at Mundipharma since December 2022, Lisa previously served as Head of Pipeline & Portfolio Strategy at Gyroscope Therapeutics, where significant advancements in gene therapy were achieved. Prior roles include Chief Project and Development Officer at Oxford BioMedica and Vice President at Shire, where Lisa led high-performing teams and defined successful strategies for product lifecycle management. With earlier experience at Covance, Schering-Plough Pharmaceuticals, and Lorex Synthelabo, Lisa has cultivated a comprehensive understanding of clinical research and project management, supported by a strong educational foundation in Microbiology and Virology from the University of Warwick.